πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 3,720 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 10548948

Methods of treating fungal infections

United States of America as represented by the Secretary of the Air Force Β· Granted Tue Feb 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10544085

Oils having antibacterial activity

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Jan 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10544392

Methods of isolating T cells and T cell receptors having antigenic specificity for a cance

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jan 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10543257

Lentiviral vector for treating hemoglobin disorders

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jan 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10544406

Characterization of four prophage endolysins specific for clostridium perfringens

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Jan 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10543268

Genetically engineered swine influenza virus and uses thereof

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Jan 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10537577

Compounds and compositions for ossification and methods related thereto

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Jan 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10538590

Photosensitizing antibody-fluorophore conjugates

The United States of America as Represented by the Secretary, Dept. of Health and Human Services Β· Granted Tue Jan 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10538749

Mutant OPAA enzymes with increased catalytic efficiency on cyclosarin

The United States of America as represented by the Secretary of the Army Β· Granted Tue Jan 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10532022

Whole stablized olive mill process water, production thereof and uses thereof

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Jan 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10531654

Methods and compositions for vein harvest and autografting

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Jan 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10526297

Benzylideneguanidine derivatives and therapeutic use for the treatment of protein misfoldi

United Kingdom Research and Innovation Β· Granted Tue Jan 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10525123

Methods for inducing an immune response against human immunodeficiency virus infection in

The Government of the United States, as represented by the Secretary of the Army Β· Granted Tue Jan 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10525101

Methods of treating inflammatory or autoimmune disorders with compounds that bind macropha

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Jan 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10519222

Broadly neutralizing monoclonal antibodies against HIV-1 V1V2 Env region

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Dec 31 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10517890

Triggering RNA interference with RNA-DNA and DNA-RNA nanoparticles

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Dec 31 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10517920

Antibacterial peptide and method of treatment using the antibacterial peptide

UNITED ARAB EMIRATES UNIVERSITY Β· Granted Tue Dec 31 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10513543

Antigen chimera, antigen composition, vaccine, method of preparing the same and cassette t

SHANGHAI UNITED CELL BIOTECHNOLOGY CO., LTD. Β· Granted Tue Dec 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10512671

IL-24 to treat inflammatory diseases

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Dec 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10512673

Use of peptide-based inhibitors of the stat3-IL10 pathway for treating bacterial infection

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Dec 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10513542

Minicircle DNA vector vaccine platform for foot-and-mouth disease and methods thereof

The Government of the United States of America, as represented by the Secretary of Homeland Security Β· Granted Tue Dec 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10513521

Compositions and methods for inhibiting BMP

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Dec 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10513494

Methods, compounds, and compositions for anesthesia

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Dec 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10513533

Tunicamycin related compounds with anti-bacterial activity

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Dec 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted